Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The resistance of lung cancer to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is one of the unconquered frontiers in chemotherapy. Mitogen-inducible gene 6 (Mig-6) is known to inhibit the kinase activity of epidermal growth factor receptor (EGFR). | Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma